Showing articles with keyword: riyi shi | CLEAR

Chris Rochet and Riyi Shi
April 26, 2018

CTSI-Supported Researchers Identify ‘Key’ Molecule in Parkinson’s Disease

By Steve Tally
A molecule has been identified that appears to play an important role in the development of¬†Parkinson’s disease, a debilitating disease that affects millions of people around the world.
A key factor in the development of Parkinson’s disease has been identified by a team of researchers at Purdue University. Jean-Christophe (Chris) Rochet, professor in the Department of Medicinal Chemistry and Molecular Pharmacology in the College of Pharmacy (left) and Dr. Riyi Shi, professor in the Department of Basic Medical Sciences, College of Veterinary Medicine and Weldon School of Biomedical Engineering. (Purdue University photo by Alex Kumar)
The discovery could lead...

April 12, 2017

Purdue Study Finds Chemical-Weapon Antidote Shows Early Promise As Spinal Cord Injury Treatment

Indiana CTSI-supported research by Purdue University investigators has found that a Word War II-era chemical-weapon antidote shows early promise as a new treatment for spinal cord injuries.
Riyi Shi, a professor of neuroscience and biomedical engineering at Purdue, and Ran Tian, a graduate student at Purdue’s Weldon School of Biomedical Engineering, discovered that the antidote, a drug called dimercaprol, is effective at suppressing a neurotoxin that worsens the pain and severity of spinal cord injuries.
Read more: http://bit.ly/2o6LwSi